Concurrent inhibition of TLR4/MD2 and EGFR is a novel strategy for cancer treatment
- YU, Z. (Plenary/keynote speaker)
Activity: Conference/talk/lecture/symposium/speech/workshop, etc › Event organized by non-HKBU units
Activity: Conference/talk/lecture/symposium/speech/workshop, etc › Event organized by non-HKBU units